Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Sea With Inc. is currently navigating 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is handled by 1 distinct examiner, BURKHART, MICHAEL D, who is the busiest examiner with 1 pending action. The prosecution is centralized in 1 distinct art unit, reflecting a singular focus for the company's active patent matters.
With 1 pending office action, the company's immediate progress at the patent office depends on the interaction with BURKHART, MICHAEL D. This 1 distinct examiner will provide the critical feedback necessary to advance the application. The 1 distinct art unit involved will set the technical and legal standards for the review. This concentrated structure suggests that the company's current patent strategy is focused on a specific niche or a single family of applications.
For practitioners, this profile represents a straightforward prosecution scenario with no examiner or art unit overlap to manage. The 1 pending office action is the only active matter, making its resolution the top priority. The focused nature of this 1-to-1-to-1 structure allows for a dedicated response strategy and simplifies the communication chain for the applicant.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BURKHART, MICHAEL D | 1 | 62.4% | +11.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18564318 | SCAFFOLD FOR CELL CULTURE | BURKHART, MICHAEL D | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18564318 | SCAFFOLD FOR CELL CULTURE | BURKHART, MICHAEL D | 1638 | §112 | Final Rejection | — | Pending | Nov 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSea With Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Michael D Burkhart has the most, with 1 of Sea With Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.